Gunderson Alisia C, Andres Brendan, Gunderson Joseph R, Sabottke Carl, Savir-Baruch Bital, Ainapurapu Bujji
Department of Medicine, University of Arizona College of Medicine, Tucson, AZ.
Division of Gastroenterology and Liver Disease, University Hospitals Cleveland Medical Center/Case Western Reserve University, Cleveland, OH.
ACG Case Rep J. 2025 Sep 4;12(9):e01819. doi: 10.14309/crj.0000000000001819. eCollection 2025 Sep.
Hepatic hydrothorax (HH) occurs in 4%-12% of patients with cirrhosis and rarely presents without accompanying evidence of clinically significant portal hypertension (CSPH). We report the case of a 65-year-old man with cirrhosis without prior decompensation, congestive heart failure, and recurrent right-sided pleural effusion. CSPH was not otherwise observed despite thorough laboratory, radiologic, and endoscopic evaluation. However, pleural fluid analysis revealed a serum effusion albumin gradient of 1.6, raising suspicion for a hepatic etiology. Suspected HH was diagnosed by technetium-99m sulfur colloid peritoneal cavity scintigraphy. As the index decompensating event, the patient's HH initiated a liver transplant evaluation in the absence of other evidence of CSPH.
肝性胸水(HH)见于4%-12%的肝硬化患者,且很少在无临床显著门静脉高压(CSPH)相关证据的情况下出现。我们报告一例65岁男性患者,患有肝硬化,此前无失代偿、充血性心力衰竭及复发性右侧胸腔积液。尽管进行了全面的实验室、影像学和内镜评估,但未发现其他CSPH证据。然而,胸水分析显示血清-胸水白蛋白梯度为1.6,这引发了对肝源性病因的怀疑。通过锝-99m硫胶体腹腔闪烁扫描术诊断为疑似HH。作为首次失代偿事件,该患者的HH在无其他CSPH证据的情况下启动了肝移植评估。